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Two phosphodiesterases from Ustilago maydis share 
structural and biochemical properties with non-fungal 
phosphodiesterases
Charu Agarwal†, David J. Schultz† and Michael H. Perlin*†
Department of Biology, Program on Disease Evolution, University of Louisville, Louisville, KY, USA
The dependence of Protein Kinase A (PKA) activity on cAMP levels is an important facet of 
the dimorphic switch between budding and filamentous growth as well as for pathogenicity in 
some fungi. To better understand these processes in the pathogenic fungus Ustilago maydis, we 
characterized the structure and biochemical functions of two phosphodiesterase (PDE) genes. 
Phosphodiesterases are enzymes involved in cAMP turnover and thus, contribute to the regulation 
of the cAMP-PKA signaling pathway. Two predicted homologs of PDEs were identified in the 
genome of U. maydis and hypothesized to be involved in cAMP turnover, thus regulating activity 
of the PKA catalytic subunit. Both umpde1 and umpde2 genes contain domains associated 
with phosphodiesterase activity predicted by InterPro analysis. Biochemical characterization of 
recombinantly produced UmPde1 (U. maydis Phosphodiesterase I) and UmPde2 demonstrated 
that both enzymes have phosphodiesterase activity in vitro, yet neither was inhibited by the 
phosphodiesterase inhibitor IBMX. Moreover, UmPde1 is specific for cAMP, while UmPde2 has 
broader substrate specificity, utilizing cAMP and cGMP as substrates. In addition, UmPde2 was 
also found to have nucleotide phosphatase activity that was higher with GMP compared to AMP. 
These results demonstrate that UmPde1 is a bona fide phosphodiesterase, while UmPde2 has 
more general activity as a cyclic nucleotide phosphodiesterase and/or GMP/AMP phosphatase. 
Thus, UmPde1 and UmPde2 likely have important roles in cell morphology and development 
and share some characteristics with a variety of non-fungal phosphodiesterases.
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signaling pathways (Lengeler et al., 2000; D’Souza and Heitman, 
2001). Both pathways play important roles in sensing signals from 
the environment, e.g., nutrient availability, pH, presence of lipids, 
and pheromones from opposite mating type, and in the transition 
between budding and filamentous growth forms (Klose et al., 2004; 
Martinez-Espinoza et al., 2004).
The U. maydis cAMP-PKA signaling pathway plays an impor-
tant role in development and virulence (Gold et al., 1994; Lee et al., 
2003). Components of cAMP-PKA signal transduction pathways 
are conserved among distinct fungal species as well as between dis-
tinct organisms, e.g., fungi to humans. Several components of the U. 
maydis PKA signaling pathway have been studied in detail (Figure 1). 
Mutations in the gene encoding the regulatory subunit, ubc1, of PKA 
result in a constitutively active PKA and result in a multiple budding 
phenotype (Gold et al., 1997). In contrast, mutations in the genes 
encoding adenylate cyclase, (uac1) the alpha subunit of a heterot-
rimeric G protein (gpa3) or the catalytic subunit of PKA (adr1) result 
in a constitutive filamentous phenotype that is caused by low PKA 
activity (Barrett et al., 1993; Regenfelder et al., 1997; Durrenberger 
et al., 1998). Collectively, these studies clearly establish the impor-
tance of cAMP levels (and control of these levels) as an important 
aspect of PKA activity and subsequent control of growth forms.
Cyclic nucleotides are important secondary messenger molecules 
in cells and their cellular levels are regulated not only by controlling 
production, but also by cyclic nucleotide phosphodiesterases that 
IntroductIon
Morphological transformation from a yeast-like budding form to 
an infectious filamentous form associated with invasive growth 
within host tissue is an important requirement for many pathogenic 
fungi. The Basidiomycete fungal pathogen Ustilago maydis is an 
excellent model system to study this dimorphic transition and for 
the analysis of the molecular basis of plant pathogenicity (Bölker, 
2001; Feldbrugge et al., 2004; Garcia-Pedrajas and Gold, 2004; Huai 
et al., 2004; Garcia-Pedrajas et al., 2008; Gouy et al., 2010). It can 
be cultured easily on artificial plates in laboratory settings and 
various molecular biology techniques can be applied to this system, 
such as, gene disruption, transformation etc. Also, its genome has 
been sequenced and is available publicly at http://mips.helmholtz-
muenchen.de/genre/proj/ustilago (Kämper et al., 2006).
To penetrate and colonize plant tissue U. maydis requires dikary-
otic, filamentous hyphae that result from fusion of haploid bud-
ding, yeast-like cells of opposite mating type (Bölker et al., 1992; 
Snetselaar et al., 1996). Infection results in the development of a 
tumor at the site of colonization and ultimately leads to production 
of diploid teliospores. These teliospores are then disseminated by 
air or water and germinate under favorable conditions, thus starting 
the life cycle anew (Banuett and Herskowitz, 1996).
Dimorphic transition in U. maydis is regulated by two conserved 
signaling cascades, namely, the MAPK (mitogen-activated protein 
kinase) and cAMP-PKA (cyclic AMP dependent-protein kinase A) 
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In addition to known roles in modulating/regulating cell mor-
phology in fungi and metabolism in mammalian systems, PDEs have 
roles in stress response. For example, in S. cerevisiae, mutants deleted 
in PDEs fail to grow on rich media after 30 min of heat shock at 55°C, 
thus indicating an important role in heat shock response (Sass et al., 
1986). Another important step in the regulation of the level of sec-
ondary messenger molecules is compartmentalization of the activity 
of phosphodiesterases so that localized cAMP/cGMP signals can be 
generated to regulate different physiological responses. In T. cruzi, 
two membrane bound cAMP-specific phosphodiesterases have been 
identified; TcrPDEB2 is concentrated in the flagellum (D’Angelo 
et al., 2004), while TcrPDEC2 is possibly associated with vesicular 
membranes (Alonso et al., 2006), thus indicating the localized level 
of cAMP is important in this parasite (D’Angelo et al., 2004) as has 
also been shown for mammalian systems (Smith and Scott, 2006).
Levels of cAMP influence growth and development in a diverse 
array of organisms and can be altered either through increased pro-
duction via adenylate cyclase or degradation via cAMP phosphodi-
esterase. Despite broad genetic studies of PDEs, there is a paucity 
of data on the biochemical nature of fungal PDEs, with S. cerevisiae 
and C. albicans being the primary fungal species for which bio-
chemical characterization exists (Nikawa et al., 1987; Hoyer et al., 
1994). Thus, as a first step toward a more complete understanding 
of the cAMP mediated cell morphology transition in U. maydis, 
we sought to analyze the sequence of PDEs in this organism and 
to better define the biochemical properties of the gene products. 
These U. maydis phosphodiesterases were found to have typical 
domains of phosphodiesterases based on InterPro analysis (Hunter 
et al., 2009). UmPde1, contains a PDEase-I domain, as well as hav-
ing a predicted membrane-spanning domain and was found to be 
specific for cAMP using in vitro assays of recombinant protein; 
UmPde2, has a cAMP phosphodiesterase class II domain and, using 
in vitro assays of recombinant protein, was found to have a broader 
substrate specificity for both cAMP and cGMP. Along with phos-
phodiesterase activity, recombinant UmPde2 was also found to have 
nucleotide phosphatase activity wherein adenosine or guanosine 
5′-monophosphates were converted to the corresponding nucle-
osides. Both of these PDEs are resistant to the known phosphodi-
esterase inhibitor, IBMX, a characteristic atypical of fungal PDEs 
examined so far, but also observed for some PDEs of Dictyostelium 
discoideum and for a subset of human and trypanosomatid PDEs.
MaterIals and Methods
MedIa and straIns used
LB media (Yeast extract 0.5%, Bacto-tryptone 1% and NaCl 1%) 
was used for growth of bacteria. Escherichia coli strains, DH5α 
(Bethesda Research Laboratories) and TOP10 (Invitrogen, USA), 
were used for all cloning and plasmid amplification. E. coli strains 
Rosetta2 (DE3) (Novagen, La Jolla, CA, USA) and BL21 (DE3) pLysS 
(Novagen) were used for expression analysis. Plasmid, pET30b, was 
purchased from Novagen (La Jolla, CA, USA). Nucleotides and 
IBMX were purchased from Sigma (St. Louis, MO, USA).
IsolatIon and expressIon of genes
Full-length ORFs of the genes were amplified by PCR. The pde1 
gene was amplified using primers 02531overexpA (5′-ATCGATC
ACATATGAGCTCTGTCGTCGA-3′) and 02531overexpB (5′-CGT
deplete the levels of cyclic nucleotides. Phosphodiesterases (PDEs) 
hydrolyze the phosphodiester bond of cyclic nucleotides and con-
vert them into monophosphates. There are 11 different families of 
phosphodiesterases that have been identified in humans according 
to sequence, regulation, biochemical properties and substrate spe-
cificity (Mehats et al., 2002). In contrast, fungi typically have two 
genes encoding cyclic phosphodiesterases (Ramanujam and Naqvi, 
2010), with, for example, Saccharomyces cerevisiae and Cryptococcus 
neoformans each possessing a Class I and a Class II PDE. As one of 
the key components of cAMP-dependent signaling pathways, PDEs 
have been studied in detail in many fungal systems, including S. 
cerevisiae and Schizosaccharomyces pombe, in mammalian systems, 
and in human fungal pathogens such as, Candida albicans, C. neo-
formans (Sass et al., 1986; Nikawa et al., 1987; Hicks et al., 2005; Jung 
et al., 2005) as well as human parasites such as the trypanosomatids, 
Trypanosoma cruzi and T. brucei (Walter and Opperdoes, 1982; 
D’Angelo et al., 2004; Alonso et al., 2006, 2007).
Figure 1 | Proposed model indicating roles of umPde1 and umPde2 in 
the cAMP signaling pathway. A morphogenic switch is regulated by the PKA 
pathway via several components. Adenylate cyclase (Uac1) is activated by 
Gα-protein in response to environmental cues and converts ATP into cAMP. 
The cAMP binds with the regulatory subunit of PKA (Ubc1) causing it to 
dissociate from the catalytic PKA subunit. The active, derepressed catalytic 
subunit of PKA (Adr1) then targets downstream transcription factors and other 
proteins. UmPde1 and UmPde2 function to convert cAMP into AMP. This 
activity leads to continued repression of PKA activity due to Adr1 repression 
by Ubc1. Solid lines indicate known components of the pathway. The dashed 
line indicates a putative feedback regulation of UmPde1 and UmPde2 by 
phosphorylation through activated PKA. White squares of Ubc1 indicate 
unbound cAMP binding sites.
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were resuspended in 1 ml lysis buffer and sonicated (see below). 
For large-scale recombinant protein production, after harvesting 
cells from induced 100 ml cultures, the sample was resuspended 
in 7 ml lysis buffer (50 mM Tris–HCl, 5% Glycerol and 50 mM 
NaCl, 7.5 kU/ml Lysozyme, 0.1 mM PMSF and 25 U/ml DNase, pH 
7–8) per gram of wet weight of pellet and was then sonicated on 
ice (Ultrasonic Homogenizer – Cole Parmer Instrument Co.) for 
at least five times for 30 s with an interval of 1 min. The sonicated 
cell extract (crude enzyme extract) was then used for all further 
enzymatic analysis.
Protein concentrations were measured by Coomassie Plus 
Protein Assay (Pierce, Rockford, IL, USA). Protein was normal-
ized in all the samples and then 10 μg of protein was loaded onto 
a 4–15% gradient Tris–HCl SDS-PAGE gel (Biorad, Hercules, CA, 
USA) to check for the expression of the protein of interest.
Gels were stained with Coomassie brilliant blue R250 in 40% 
methanol, 40% water, and 10% acetic acid overnight. For de-stain-
ing 7.5% acetic acid was used and microwave was used to expedite 
the process.
phosphodIesterase assay
Phosphodiesterase assays were performed using crude pro-
tein extracts. The assay was modified from the protocol used by 
Abbott and Thompson (2005). Briefly, 0.1 mg crude protein extract 
(described above) was supplied with substrate (1 mM cAMP, cGMP, 
AMP, ADP, ATP, GMP, adenosine, or guanosine) in 0.1 ml 9 mM 
HEPES buffer (Abbott and Thompson, 2005). Reactions were ini-
tiated by addition of protein and were incubated at 25°C for 1 h 
without shaking. Reactions were terminated by heating to 100°C 
for 3 min. The samples were then stored at 20°C until analyzed by 
reversed phase HPLC.
analysIs by rp-hplc
For analysis of assay substrates and products, Shimadzu LC-10 
ADVP Liquid Chromatograph was used. Shimadzu’s SPD-10ADVP 
UV-VIS detector was used for detection of peaks at 254 nm. Prior 
to sample injection, the column (Shimadzu, premier RP-C18, 
25 cm × 4.6 mm, 120Å pore diameter, 5 μm particle diameter) 
was equilibrated with 50 mM ammonium di-hydrogen phosphate 
buffer with 10% methanol at a flow rate of 0.75 ml/min. Samples 
were centrifuged to pellet the cell debris. Aliquots of 20 μl from 
the supernatant were injected onto RP-HPLC column. Samples 
were injected manually by syringe with a Rheodyne injector, 7725i, 
with 20 μl SS sample loop. Isocratic conditions were used during 
the separation of nucleotides. Specific activity of crude protein 
extracts was calculated as nmol product formed/min/mg of crude 
protein. Activity of control samples (vector with no PDE insert) 
was subtracted in each case as background activity. The assays were 
performed in three independent replicates for each enzyme prepa-
ration and standard deviation was calculated.
results
structural analysIs of pdes
Currently, there are no annotations of ORFs as PDEs in MUMDB1. 
Possible U. maydis phosphodiesterases were identified by the InterPro 
domain search available on this website. Six putative ORFs were iden-
tified: um02531 (IPR002591, Type I  phosphodiesterase/nucleotide 
GCTGAATTCTTATAAACCGTCTCGAAGG-3′) and the pde2 gene 
fragment was amplified using primers 10895overexpA (5′-AGAGTA
TCGCATATGTTCAATGGCAAGATCTGG-3′) and 10895overexpB 
(5′-CGTGCTGAATTCTCAATACGCATGCCCTTTTCTG-3′). The 
A and B primers were designed, respectively, to contain NdeI and 
EcoRI restriction sites, indicated by italics Phusion DNA polymerase 
(Finnzymes, Lafayette, CO, USA) was used to reduce introduction 
of errors during PCR. Fragments were then cloned into TOPO TA 
vector (Invitrogen). The construct was then digested with NdeI 
and EcoRI and the gene fragments were then cloned into pET30b 
vector, digested with the same enzymes, to obtain UmPde1-pET30b 
and UmPde2-pET30b constructs. The construct for expressing a 
variant of UmPde1 deleted for the membrane-spanning domain, 
AA87UmPde1-pET30b, was obtained in the same manner except 
the primers 02531-AA87OEPE (5′-ATCGATCACATATGCACAC
CGTCCGACCGTG-3′) (see Figure 2A, *, for location relative to 
predicted transmembrane domain) and 02531overexpB were used. 
Restriction analysis was performed to check for the correct insert 
orientation and the constructs were then sequenced to verify the 
gene sequence.
The UmPde1-pET30b, UmPde2-pET30b and AA87UmPde1-
pET30b constructs and the empty pET30b vector were transformed 
into the BL21 (DE3) pLysS and the Rosetta2 (DE3) E. coli strains.
In sIlIco analyses and phylogenetIc Inference
InterPro searches were conducted on the MIPS U. maydis Database 
(MUMDB1) to identify possible ORFs containing phosphodi-
esterase domains. Conserved domains were identified using the 
NCBI (National Center for Biotechnology Information) Conserved 
Domain Search Program2. Regions of hydrophobicity indicating 
possible membrane-spanning domains were screened using Protein 
Hydrophobicity Plot tool in the Molecular Toolkit3 and TargetP 
1.1 (Emanuelsson et al., 2000) was used to search for presence of 
signal peptides indicative of targeting to sub-cellular organelles. 
Amino acid sequence alignments were performed with ClustalW 
(Thompson et al., 1994). The unrooted Phyl-ML trees were gen-
erated by the seaview4 package of phylogenetic software (Gouy 
et al., 2010), employing the WAG model for ML analysis. Support 
for major branches was calculated by phylogenetic analysis in 
PAUP4.0b10 using a Full Heuristic search with Bootstrap analysis 
of 1000 replicates.
productIon of recoMbInant pde proteIns
Overnight culture (4 ml LB supplemented with appropriate antibi-
otics) was used as inoculum (0.2%) for larger cultures (100 ml LB 
supplemented with appropriate antibiotics). Protein expression was 
induced by addition of IPTG to 0.75 mM in larger cultures when 
they reached an absorbance at 600 nm (A
600
) = 0.4–0.6.
To determine optimal protein expression, time course studies 
were used to assess production of recombinant protein in crude 
cell extracts. Aliquots (2 ml) were taken at 0, 2, 4, 8, and 16 h after 
induction. For crude cell extracts, 1 ml of culture was centrifuged at 
10,000 × g for 1 min and the supernatant was removed. Cell pellets 
1http://mips.helmholtz-muenchen.de/genre/proj/ustilago
2http://www.ncbi.nlm.nih.gov/structure/cdd/wrpsb.cgi
3http://www.vivo.colostate.edu/molkit/hydropathy/index.html
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Figure 2 | Analysis of primary structure and phylogeny for umPde1 and 
umPde2. (A) Schematic diagram of UmPde1 with several closely related PDEs 
showing catalytic domain (indicated as large rectangles; COG 3379 for UmPde1, 
pfam 01663 for the remaining proteins) and transmembrane domain (small 
rectangles at N-terminal portions of the respective proteins, along with amino acid 
residue numbers comprising the domains). “P” indicates putative phosphorylation 
site by PKA in UmPde1; *, represents location of the 5′ primer used to produce a 
gene encoding a version of UmPde1 lacking the predicted membrane-spanning 
domain; (B) Alignment of UmPde2 primary sequence with that for EcPDEPho (NCBI 
Accession No. AP_003606). EcPDEPho is an Escherichia coli fused tRNA nucleotidyl 
transferase and 2′3′-cyclic phosphodiesterase/2′nucleotidase/phosphatase. The 
putative pfam02112, cAMP phosphodiesterase II domain, of UmPde2 is delineated 
by blue square brackets, while the HDc domain of EcPDEPho is bounded by green 
vertical lines. The predicted PKA target sites in UmPde2 are highlighted in red. (C) 
Unrooted tree showing relationship of UmPde2 catalytic domain compared to those 
of two PDEs from basidiomycetous and one ascomycetous fungi, as well as those 
from several bacteria. The EcCpdB (Accession No. P08331) and BsPhoD (Accession 
No. AAB47803) represent enzymes shown to have both cyclic phosphodiesterase 
and nucleotide phosphatase or cyclic phosphodiesterase and alkaline phosphatase 
activities, respectively.
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indicated that 4 h post-IPTG induction, protein expression did 
not increase significantly relative to total proteins, therefore the 
4-h time point was used in all activity experiments.
phosphodIesterase actIvIty
Phosphodiesterase activity was analyzed using freshly prepared 
crude protein extracts of 4 h induced cultures since no activity 
was detected in frozen samples. HPLC analysis was used to identify 
assay products and unreacted substrate relative to retention times 
of authentic standards. Background (empty vector) activity was 
subtracted from all samples to eliminate any potential endogenous 
E. coli activities.
When supplied with cAMP, both UmPde1 and UmPde2 pro-
duced a strong AMP product signal (Figure 3). In the vector alone 
sample (Figure 3A) one major cAMP peak was present and two 
minor peaks that correspond to AMP and adenosine were observed. 
UmPde1 showed a dominant AMP peak and minor cAMP and 
adenosine peaks (Figure 3B). In UmPde2 samples two major peaks 
that corresponded to AMP and adenosine and one minor cAMP 
peak were observed (Figure 3C). Specific activities for one set of 
replicates (shown in Figure 4) were calculated to be 8.62 nmol 
AMP produced/min/mg protein and 1.10 nmol adenosine pro-
duced/min/mg of protein for UmPde1 and 6.61 nmol AMP pro-
duced/min/mg protein and 4.76 nmol adenosine produced/min/
mg protein for UmPde2. Thus, UmPde1 is predominantly a cyclic 
PDE, while UmPde2 displays both PDE and phosphatase activities. 
Due to this latter finding, we conducted additional alignments of 
UmPde2 predicted amino acid sequence with those of two E. coli 
enzymes exhibiting dual functions (E. coli PDEPho, Figure 2B, and 
E. coli CpdB, not shown). There was a high degree of amino acid 
similarity with each and phylogenetic analyses placed UmPde2 
together with EcPDEPho when compared with several other bac-
terial phosphodiesterases and with PDEs from basidiomycetous 
fungi (Figure 2C).
substrate specIfIcIty profIle
Based on computational analysis of the gene sequence, we predicted 
both UmPde1 and UmPde2 would contain cAMP phosphodieste-
rase activity. The discovery of a strong peak corresponding to ade-
nosine in UmPde2 samples suggested the potential for an additional 
activity and necessitated deriving a more complete substrate specifi-
city profile of both UmPde1 and UmPde2. The two most common 
cyclic nucleotides (cAMP and cGMP) with roles in signaling were 
analyzed as substrates for each enzyme. We found that UmPde1 
was specific for cAMP and did not hydrolyze cGMP in these experi-
ments (Table 1). In contrast, for UmPde2, along with conversion 
of cAMP into AMP, this enzyme was also able to convert cGMP 
into GMP (Table 1). In comparing complete metabolism of cyclic 
nucleotides into nucleoside 5′-monophosphates and nucleosides, 
UmPde2 displayed roughly threefold higher activity when supplied 
with cAMP compared to cGMP. In contrast, when supplied with 
nucleoside 5′-monophosphates, the rate of production of nucle-
osides was 1.8-fold higher for GMP compared with AMP.
UmPde1 did not convert nucleoside 5-monophosphates (AMP 
and GMP) into adenosine or guanosine, respectively (Table 1). 
UmPde1 and UmPde2 were also assayed with ADP and ATP as 
substrates. However, in the vector alone samples, ADP and ATP 
pyrophosphatase), um10895 (IPR000396, cAMP phosphodiesterase, 
class II), um04961 (IPR002073, 3′,5′-cyclic nucleotide phosphodi-
esterase), um12014/um00004 (IPR004129, glycerophosphoryl ester 
phosphodiesterase), um00989 (IPR010347,  tyrosyl-DNA phos-
phodiesterase), and um12190/um02441 (IPR0012386, 2′3′-cyclic 
phosphodiesterase, plant; IPR009097, RNA ligase/cyclic nucleotide 
phosphodiesterase). With the exception of um02531 (annotated 
as “related to nucleotide diphosphatase”), all the remaining ORF 
entries were annotated as “conserved hypothetical proteins.” We 
focused on ORFs um02531 and um10895, whose predicted InterPro 
domains and overall size matched more closely with participants in 
the cAMP-dependent PKA pathway governing cell morphology and 
pathogenicity of U. maydis. These ORFs, um02531 and um10895, 
will hereafter be referred to, respectively, as umpde1 and umpde2. 
A Conserved Domain Search at NCBI predicted that U. maydis 
UmPde1 contains a COG3379 domain, similar to pfam01663, type I 
phosphodiesterase/nucleotide pyrophosphatase, and UmPde2 con-
tains a phosphodiesterase domain, pfam02112, for cAMP phos-
phodiesterase, class_II (See Figures 2A,B). The predicted UmPde1 
also has a hydrophobic N-terminal portion, suggesting that it con-
tains a transmembrane region from amino acid 67 to amino acid 
89. As seen in Figure 2A, this feature is also found in other fungal 
PDEs, and in human HsPde1 and HsPde3A, B (not shown). Both 
UmPde1 and UmPde2 sequences were analyzed using TargetP for 
presence of signal peptides to evaluate any possible targeting to sub-
cellular organelles. No such signal sequence was identified in either 
umpde1 or umpde2. Neither UmPde1 nor UmPde2 were predicted 
to contain any additional N-terminal domains found in other PDE 
classes; GAF (cGMP-binding phosphodiesterase, Anabaena adeny-
lyl cyclase, E. coli FhlA) domains common to a number of vertebrate 
classes of PDEs and to TcrPDEB1 and TcrPDEB2 from T. cruzi, 
were absent in UmPde1 and UmPde2.
Phosphodiesterases are a key component of the cAMP-PKA sig-
naling pathway. Regulation of PKA pathway components is thus 
very important for virulence and growth of the fungus. Many 
components of the pathway are regulated by post-translational 
covalent modification (phosphorylation/dephosphorylation). To 
examine the potential for regulation by phosphorylation, both 
PDEs were assessed for PKA phosphorylation target sequences 
using NPS PROSCAN (Combet et al., 2000). UmPde1 was found 
to contain one putative PKA phosphorylation site (residues 64–67) 
while UmPde2 contains four putative PKA phosphorylation sites 
(Figure 2B). In addition, eight putative sites for phosphorylation 
by PKC were also predicted (not shown).
expressIon of pdes
Production of recombinant umpde1 and umpde2 ORFs cloned 
into the pET30b (+) vector failed in BL21 (DE3) pLysS (data not 
shown). To address potential problems with codon bias, expression 
was also attempted in Rosetta2 (DE3). UmPde2 was detectable as 
a ∼56 kDa band in the Rosetta2 (DE3) E. coli strain. Full-length 
UmPde1 was also not expressed in the Rosetta2 (DE3) strain when 
a predicted membrane-spanning domain was included. However, 
expression was detected in the Rosetta2 (DE3) when a derivative 
of the umpde1 gene, present in AA87UmPde1-pET30b, was used 
in which the region encoding the predicted membrane-spanning 
domain was deleted. Time course analysis of protein expression 
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were converted into AMP at a high rate and thus production of 
corresponding activity of UmPde1 and UmPde2 toward ATP, ADP 
or AMP could not be differentiated.
response to IbMx
To characterize UmPde1 and UmPde2 activity with respect 
to a known cyclic phosphodiesterase inhibitor and thus bet-
ter define UmPde2 as a cyclic phosphodiesterase or nucleoside 
5′-monophosphatase, assays were conducted in the presence of 
IBMX. Three concentrations of inhibitor were tested (10 μM, 
500 μM, and 1 mM) and compared to vehicle control (DMSO only). 
Figure 3 | Sample rP-HPLC chromatograms of (A) empty vector sample 
with a major peak for cAMP; (B) UmPde1 expressed sample showing one 
major product peak for AMP; (C) UmPde2 expressed sample showing two 
major product peaks, for AMP and for Adenosine. AMP, adenosine 
monophosphate, cAMP, cyclic AMP.
Table 1 | Substrate specificity for umPde1 and umpde2.
 % Product
Substrate used umPde1 umPde2
cAMP 67 (AMP+Adeno) 72 (AMP+Adeno)
cGMP N.D. 11 (Guano)
AMP N.D. 34 (Adeno)
ADP N.D. 34 (Adeno)
ATP N.D. 34 (Adeno)
GMP N.D. 63 (Guano)
Different nucleotides were used as substrates for UmPde1 and UmPde2 and 
their conversion into subsequent product was measured via RP-HPLC and 
tabulated for comparison. Activity in vector alone sample was subtracted as 
background activity.
N.D., none detected; Adeno, adenosine; Guano, guanosine; AMP, adenosine 
monophosphate.
Figure 4 | Specific activities of umPde1 and umPde2. cAMP was 
converted into AMP by both the enzymes. Both UmPde1 and UmPde2 were 
able to convert AMP into adenosine, though this activity was more 
pronounced in UmPde2. Bars indicate standard deviation obtained from three 
independent replicate assays for each enzyme.
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as a phosphodiesterase and as a phosphatase. Interestingly, here 
UmPde2 prefers GMP over AMP as a substrate. In yeast, Pde1 can 
convert both cAMP and cGMP into AMP and GMP, respectively, but 
the high affinity phosphodiesterase Pde2 was found to be involved 
in hydrolysis of cAMP specifically (Londesborough, 1977). Thus, 
UmPde2 shows biochemical similarity to Pde1 of S. cerevisiae and 
with the Pde1 of D. discoideum, which is also resistant to IBMX. 
UmPde2 also acts as a nucleotide phosphatase, thus showing dual 
functions both as a phosphodiesterase and as a phosphatase. In 
several bacteria it has been shown that phosphodiesterases can 
have dual function, acting both as phosphodiesterase as well as an 
AMP phosphatase (Liu et al., 1986; Fouts et al., 2008) or alkaline 
phosphatase (O’Brien and Herschlag, 2001; Zhang et al., 2005). For 
example, the E. coli and B. subtilis alkaline phosphatases were shown 
to have phosphodiesterase activity on bis-p-nitrophenyl phosphate, 
bis-pNPP (O’Brien and Herschlag, 2001). Interestingly, alignments 
of UmPde2 with two E. coli enzymes exhibiting dual functions (E. 
coli PDEPho, Figure 2B, and E. coli CpdB, not shown) revealed a high 
degree of amino acid similarity and phylogenetic analyses placed 
UmPde2 together with EcPDEPho when compared with several 
other bacterial phosphodiesterases and with PDEs from basidiomyc-
etous fungi (Figure 2C).
In comparing structural similarities of U. maydis UmPde1 with 
other fungal PDEs (and with several non-fungal PDEs; Figure 2A) 
we noticed that, like these enzymes, UmPde1 has a hydrophobic 
N-terminal region predicted to serve as a membrane-spanning 
domain and we expect it to be located in the plasma membrane 
of this organism. One possible significance of such a domain is the 
observation, discussed in several reports (Cooper, 2005; Scott, 2006; 
Smith and Scott, 2006; Alonso et al., 2007), of compartmentaliza-
tion of cAMP and the importance in controlling the sub-cellular 
localization of enzymes involved in controlling available pools of this 
critical second messenger. This spatial organization of several path-
way components is shown to be governed by A-kinase anchoring 
proteins (AKAPs). Elevations in the level of cAMP and PKA activity 
by different factors command different physiological outputs. This 
compartmentalization of cAMP-PDEs is shown to be important 
for tailoring individual cAMP responses and is because of spatially 
limited access to effectors of cAMP-PKA signaling pathway and PKA 
enzyme (Smith and Scott, 2006). While our prediction that UmPde1 
spans the cytoplasmic membrane or is associated with it stems pri-
marily from in silico predictions, further support for this assertion 
stems from our inability to express the full-length protein in E. coli 
with that domain present; it was successfully expressed as a trun-
cated version removing that region. Consistent with the above fact, 
the derivative of UmPde1, with the deleted membrane-spanning 
domain, was not able to fully complement the multiple budding 
phenotype of UmPde1 deletion strains (unpublished observations). 
This suggests that UmPde1 might normally be located in the mem-
brane of this organism. While this domain is not required for phos-
phodiesterase activity in vitro, it remains to be determined whether 
and what role such membrane localization might play in vivo.
In summary, at least six enzymes were predicted to have some 
sort of phosphodiesterase activity after inspection of the U. maydis 
genome and in this report; we have confirmed that UmPde1 and 
UmPde2 are phosphodiesterases, likely involved in the modulation 
of cAMP levels in U. maydis. Based on the putative phosphorylation 
Both UmPde1 and UmPde2 were found to be insensitive to IBMX 
at these concentrations, and yielded chromatograms comparable 
to the DMSO vehicle control (data not shown).
dIscussIon
Important roles of cyclic nucleotides as second messengers in 
response to nutrient signals have been defined in many fungi 
(Rolland et al., 2002). As part of the overall system regulating  cellular 
processes via second messengers, controlling internal levels of cyclic 
nucleotides is critical. While adenylate cyclases are responsible for 
synthesis of cyclic nucleotides, the flip side of the process are the 
PDEs that facilitate turnover of these molecules. In S. cerevisiae, 
two phosphodiesterases, Pde1 and Pde2, have been characterized 
and found to be low and high affinity PDEs, respectively. They are 
involved in modulating cAMP levels under different nutrient condi-
tions, such as glucose availability, as addition of glucose to starved 
yeast cells lead to momentary increase in cAMP levels. Increased 
transcription of the gene for the low affinity phosphodiesterase, 
Pde1, is induced by addition of glucose via PKA and thus helps 
in the regulation of increased cAMP levels (Wera et al., 1997). In 
addition, there is evidence that phosphorylation of Pde1 and Pde2 
plays a role in regulating their functions (Ma et al., 1999). Similarly, 
in C. neoformans, virulence factor production is regulated by the 
cAMP-PKA cascade and both Pde1 and Pde2, which are negatively 
regulated by Pka1 and Pka2 (catalytic subunits of PKA), are spe-
cifically required during melanin and capsule production under 
stress, e.g., low iron conditions. As with other PDEs examined in 
dimorphic fungi, UmPde1 and UmPde2 appear, from in silico analy-
ses (Figure 2B), to also contain potential targets for regulation by 
protein kinases in U. maydis. Additional analyses of their predicted 
catalytic domains, suggested that each of these enzymes was phylo-
genetically similar to other PDEs containing the same pfam domains 
(Figure 5). In some cases, the clades identified in the analyses, for the 
most part reflected known substrate affinity profiles for the respec-
tive enzymes. For instance, most of the enzymes in the pfam00233/
HDc group (Figure 5) appeared to have a preference for cAMP. For 
the group II clade, both dual cAMP/cGMP specificity and IBMX 
resistance were found. On the other hand, substrate preference was 
not conserved in the group I clade. However, in both clades, insuf-
ficient biochemical data on substrate profiles and IBMX sensitivity 
prevent meaningful  conclusions about these features in relation to 
the phylogenetic groupings. Regarding IBMX sensitivity, it is clear 
from examination of the pfam00233/HDac clade and numerous 
studies of human PDE families (Huai et al., 2004, Beavo et al., 
2007) that IBMX sensitivity and PDE family do not go hand-in-
hand. Thus, the fact that both UmPde1 and UmPde2 are IBMX 
resistant, does distinguish them from other fungal PDEs character-
ized at this time, but does not directly provide insight into phyloge-
netic relationships among these and other PDEs. Additional insights 
about the U. maydis PDEs may be gained from comparisons made 
between the complete primary sequences of these proteins and their 
biochemical properties with those of other PDEs. Upon further 
biochemical analysis of these enzymes we confirmed that UmPde1 
is specific for cAMP and does not hydrolyze cGMP in contrast to 
UmPde2, which was able to act, in its role as a PDE, on both cAMP 
and cGMP, with apparent preference for the former. UmPde2 also 
acts as a nucleotide phosphatase, thus showing dual functions both 
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sites for PKA in both of these enzymes, further investigation of the 
regulation of these enzymes by phosphorylation via PKA is war-
ranted. Moreover, the similarities of these fungal enzymes in several 
important respects to phosphodiesterases of other fungi, protozo-
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about the evolution of these ubiquitous but diverse proteins.
Figure 5 | Phylogenetic analyses for a variety of PDes. This is an unrooted 
Phyl-ML tree from analysis of the catalytic domains of PDEs by Phylip as part of the 
seaview package of phylogenetic software (Gouy et al., 2010), employing the WAG 
model for ML analysis. Support for major branches is indicated from a tree showing 
the same topology, but generated by phylogenetic analysis in PAUP4.0b10 using a 
Full Heuristic search with Bootstrap analysis of 1000 replicates. The species 
abbreviations, NCBI or MUMDB (for the U. maydis PDEs) accession numbers, 
residues used, and taxonomy are: UmPde1Cat, Ustilago maydis, um02531, 
120-465, Fungi, Basidiomycota; UmPde2Cat, U. maydis, um10895, 240-345, Fungi, 
Basidiomycota; CcNPPcat, Coprinopsis cinerea okayama7#130, XP_001835792,105-
435, Fungi, Basidiomycota; PpPdeCat, Pichia pastoris GS115, XP_002490053, 
140-180, Fungi, Ascomycota; CpPde1Cat, Coccidioides posadasii C735 delta 
SOWgp, XP_003070903, 223-553, Fungi, Ascomycota; HsPde1, Homo sapiens, 
NP_006199, 200-540, Mammalia, Primates; RnPde1Cat, Rattus norvegicus, 
BAA06333, 155-480, Mammalia, Rodentia; RnPdeCat, R. norvegicus, AAB61535, 
160-480, Mammalia, Rodentia; TcrPDEB1c, Trypanosoma cruzi, AAM28249,674-
900, Euglenozoa, Kinetoplastida; TcrPDEB2c, T. cruzi, AAP49573,675-915, 
Euglenozoa, Kinetoplastida; TcrPDEC2cat, T. cruzi, AAY25022,673-600, Euglenozoa, 
Kinetoplastida; DdPDE1Cat, Dictyostelium discoideum AX4, XP_637948,98-448, 
Amoebozoa, Mycetozoa; DdPDE4C2, D. discoideum AX4, XP_636380,575-660, 
Amoebozoa, Mycetozoa; HsPDE3Bcat, H. sapiens, CAA64774, 800-960, 
Mammalia, Primates; CnPde1Cat, Cryptococcus neoformans var. neoformans 
(Filobasidiella neoformans strain JEC21), XP_568076,45-455, Fungi, Basidiomycota; 
CnPde2cat, C. neoformans var. grubii (Filobasidiella neoformans serotype A), 
AAX73257,225-525, Fungi, Basidiomycota; ScPde1C, Saccharomyces cerevisiae 
S288c, NP_011266,4-368, Fungi, Ascomycota; CcPde2Cat, C. cinerea 
okayama7#130, XP_001833477,45-400, Fungi, Basidiomycota; VfPdeCat, Vibrio 
fischeri, Q56686,25-322, Bacteria, Proteobacteria; CaPde1C, Candida albicans, 
P32782,32-420, Fungi, Ascomycota; MoPdeC1, Magnaporthe oryzae, 
XP_367803,18-180, Fungi, Ascomycota; AfPdeC1, Aspergillus fumigatus Af293, 
XP_752858,5-345, Fungi, Ascomycota; NfPdeC1, Neosartorya fischeri NRRL 181, 
XP_001264269,8-346, Fungi, Ascomycota; AcPdeC1, Aspergillus clavatus NRRL 1, 
XP_001268766,5-165, Fungi, Ascomycota; AcPdeC2, A. clavatus NRRL 1, 
XP_001268766,257-345, Fungi, Ascomycota; CpPde2Cat, C. posadasii C735 delta 
SOWgp, XP_003068881, 25-363, Fungi, Ascomycota; AcPde1Cat, A. clavatus NRRL 
1, XP_001275664,210-545, Fungi, Ascomycota; MmPde9A1c, Mus musculus, 
EDL40358,252-480, Mammalia, Rodentia; HsPde9ACa, H. sapiens, NP_002597,252-
470, Mammalia, Primates; HsPde4A, H. sapiens, NP_001104777,195-435, 
Mammalia, Primates; HsPde8ACat, H. sapiens, EAX01966,550-810, Mammalia, 
Primates. I, clade including primarily PDEs containing a pfam01663 domain; II, clade 
consisting of pfam02112 domains from selected PDEs; pfam0233/HDc, clade 
containing the 3′,5′ cyclic nucleotide phosphodiesterase and/or metal-dependent 
phosphohydrolase (HDc) domain. Locations of UmPde1 and UmPde2 in the tree are 
emphasized with * and **, respectively.
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